Stem cells

Stem cell transplant
#Graft vs Host Disease #Haematology #JAK inhibitor #Stem cells #Washington University School of Medicine

JAK inhibitor prevents GvHD in ‘half-matched’ stem cell transplants

Adding a new drug to standard care for stem cell transplant recipients may reduce graft-versus-host disease (GvHD), according to an early-stage clinical trial conducted at Washington University School of Medicine in St Louis.   The trial showed that patients being treated for various blood cancers tolerated the… Read More

#News #Trending News

Gene therapy concept
#Blood cancer #CAR-T #Cell therapy #Regenerative Medicine #Stem cells #Tune Therapeutics

Unlocking the future of medicine with cell therapy

Nathan Yee, Senior Director of CMC Portfolio Strategy at Tune Therapeutics, and Lucas Thompson, Senior Director of Research at Tune Therapeutics, discuss the opportunities and challenges in cell therapy. Cell therapy is a transformative medical approach that harnesses living cells as therapeutic agents and has demonstrated the potential to address… Read More

#Cancer Research #Exclusive Content #Opinion

Human cell
#High throughput screening #iPSC #Live cell analysis #Organoids #Phenotyping #Stem cells #Webinar

Register now: Discover a robust method for organoid development

The value of stem cells in laboratory and clinical research has been clearly demonstrated through numerous studies, showcasing their potential as models for a wide range of diseases and therapeutic developments. The inherent flexibility of stem cells allows for the development of various tissue types from a single,… Read More

Webinar date:
Supported by Sartorius
#News

Pluripotent stem cells
#High throughput screening #iPSC #Live cell analysis #Organoids #Phenotyping #Stem cells #Webinar

Webinar: Generate human hepatic organoids from iPSCs

The value of stem cells in laboratory and clinical research has been clearly demonstrated through numerous studies, showcasing their potential as models for a wide range of diseases and therapeutic developments. The inherent flexibility of stem cells allows for the development of various tissue types from a single,… Read More

Webinar date:
Supported by Sartorius
#News

#Autoimmune disease #Cell therapy #Immuno-oncology #Kiji Therapeutics #Mergers and acquisitions #Monoclonal antibodies #REGiMMUNE #Stem cells

REGiMMUNE and Kiji Therapeutics announce intention to merge

Biopharmaceutical company REGiMMUNE and biotech Kiji Therapeutics have announced an intention to merge, creating a global Treg specialist that will target multiple indications. The new company, called REGiMMUNE/Kiji TX will combine the complimentary portfolio of platforms and therapies to create an international Treg biotech. Both companies have been focused on… Read More

#Business & Investment #News

Stem cells
#High throughput screening #iPSC #Live cell analysis #Organoids #Phenotyping #Stem cells #Webinar

Webinar: Differentiate iPSCs into hepatic lineage cells and organoids

The value of stem cells in laboratory and clinical research has been clearly demonstrated through numerous studies, showcasing their potential as models for a wide range of diseases and therapeutic developments. The inherent flexibility of stem cells allows for the development of various tissue types from a single,… Read More

Webinar date:
Supported by Sartorius
#News

Organoid
#High throughput screening #iPSC #Live cell analysis #Organoids #Phenotyping #Stem cells #Webinar

Register now: Learn streamlined hepatic differentiation techniques

The value of stem cells in laboratory and clinical research has been clearly demonstrated through numerous studies, showcasing their potential as models for a wide range of diseases and therapeutic developments. The inherent flexibility of stem cells allows for the development of various tissue types from a single,… Read More

Webinar date:
Supported by Sartorius
#News

Organoid
#High throughput screening #iPSC #Live cell analysis #Organoids #Phenotyping #Stem cells

From iPSCs to Organoids: Streamlined Hepatic Differentiation Techniques

In this webinar, we describe the process of differentiating human iPSCs into hepatocytes using three distinct media types, each supplemented with specific growth factors and cytokines at key stages of differentiation. This method provides a relatively straightforward approach to producing mature hepatic cells, enabling the generation of human hepatic organoids… Read More

Webinar date:
Supported by Sartorius
#Webinars

#Artificial intelligence (AI) #Bipolar #CRISPR #Events #GLP-1 #Neuroscience #Society for Neuroscience #Stem cells

New DDW Highlights episode: 15 October 2024

The latest episode of the DDW Highlights podcast is now available to listen to and watch below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Recently, the Society for Neuroscience’s annual meeting took place, so… Read More

#News

#Artificial intelligence (AI) #Bipolar #CRISPR #Events #GLP-1 #Neuroscience #Society for Neuroscience #Stem cells

This week in drug discovery (7-11 Oct) 

News round-up for 7-11 October by DDW Senior Digital Content Editor Diana Spencer. The Society for Neuroscience annual meeting took place this week, so the headlines have been dominated by the latest discoveries related to the brain and the central nervous system, including significant findings related to GLP-1… Read More

#News

Pluripotent stem cells
#Cell therapy #Neuroscience #Pluripotent stem cells #Society for Neuroscience #Stem cells

Neuroscience 2024: Leveraging human stem cells to treat diseases

Progress in stem cell technologies is advancing powerful new ways of studying and treating formerly intractable neurological and neuropsychiatric diseases. Several interwoven examples have been discussed at Neuroscience 2024, the annual meeting of the Society for Neuroscience. Over 40% of the global population lives with some… Read More

#News #Trending News

Stem cells
#Diabetes #Phase I trial #Pluripotent stem cells #Stem cells #Type 1 diabetes

Stem cell therapy cures type 1 diabetes

A type 1 diabetes patient has been successfully treated using chemically induced pluripotent stem-cell-derived islets (CiPSC islets). The Phase I trial is the first ever example of a person with the disease being treated using cells that were extracted from their own body. The… Read More

#Editor's Choice #News

#Life sciences #Novo Nordisk Foundation #Regenerative Medicine #Stem cells

The future of regenerative medicine at Novo Nordisk Foundation

Recently, the Novo Nordisk Foundation updated its strategy to include regenerative medicine. While regenerative medicine is not new to the Foundation, it is now an explicit part of the company’s strategy. DDW’s Megan Thomas caught up with Martin Ridderstråle, Senior Vice President and Head of Medical Science at the Novo… Read More

#Business & Investment #Exclusive Content

Knee x-ray
#allogeneic cell therapies #Australia #Cell therapy #Magellan Stem Cells #Osteoarthritis #Stem cells

Donor stem cell therapy delays progression of osteoarthritis

New research by Australian biotechnology company Magellan Stem Cells has demonstrated potential therapeutic benefits of a stem cell therapy for osteoarthritis. The Phase I/II clinical trial assessed the safety and efficacy of MAG200, Magellan Stem Cells’ off-the-shelf allogeneic (donor) stem cell therapy for osteoarthritis of the… Read More

#News

Neuroscience Parkinson's disease
#Bayer #Biogen #BlueRock Therapeutics #Cell therapy #Ionis Pharmaceuticals #Mission Therapeutics #Neuroscience #Parkinson's #Small molecul #Stem cells #Vaxxinity #Vesper Bio

Exploring new frontiers in Parkinson’s Disease   

With debilitating symptoms including tremor, slow movement, rigidness and pain, Parkinson’s disease remains one of the most feared neurodegenerative conditions. DDW's Megan Thomas reports on the latest clinical progress as pharma and biotech search for new therapies for this currently incurable condition.  Parkinson’s is the most common movement disorder, affecting around… Read More

#Exclusive Content #Trends & Analysis

#Accelerated Bio #Biomanufacturing #Biotechnology #Cell engineering #Mekonos #Stem cells

New cell engineering partnership to accelerate biopharma innovation 

Mekonos, a company working towards cell engineering on a chip, has entered into a partnership agreement with Accelerated Bio to codevelop a new manufacturing cell line based on Accelerated Bio’s human Trophoblast Stem Cells (hTSCs) and Gene Engineered Multi-Sites (GEMS) technology.  Dr Anil Narasimha, Co-founder and Chief… Read More

#News